Could Gene Editing Eventually Offer a ‘One-Time’ Treatment for CVD? Carolyn Brown May 22, 2026

https://www.medscape.com/viewarticle/could-gene-editing-eventually-offer-one-time-treatment-cvd-2026a1000gsz?ecd=wnl_edit_tpal_etid8368088&uac=148436CN&impID=8368088 Cardiovascular diseases could be among the world’s first medical conditions to be treated by changing a patient’s genes. If ongoing phase 3 trials succeed, gene editing will offer a novel therapy for transthyretin amyloidosis, and treatments for hyperlipidemia may not be far behind.